Adagene (ADAG)

Adagene Stock Analysis & Ratings

ADAG Stock Chart & Stats

Day’s Range$2.81 - $2.9
52-Week Range$2.76 - $20.98
Previous Close$2.82
Average Volume (3M)32.37K
Market Cap$123.50M
P/E RatioN/A
Next EarningsMar 31, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score4
EPS (TTM)0.00



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Adagene’s price range in the past 12 months?
Adagene lowest stock price was $2.75 and its highest was $20.98 in the past 12 months.
    What is Adagene’s market cap?
    Adagene’s market cap is $123.50M.
      What is Adagene’s price target?
      Currently, no data Available
      What do analysts say about Adagene?
      Not enough analysts have published a price target to provide an average price target.
      When is Adagene’s upcoming earnings report date?
      Adagene’s upcoming earnings report date is Mar 31, 2022 which is 57 days ago.
        How were Adagene’s earnings last quarter?
        Adagene released its earnings results on Aug 26, 2021. The company reported -$0.6 earnings per share for the quarter, missing the consensus estimate of -$0.495 by -$0.105.
          Is Adagene overvalued?
          According to Wall Street analysts Adagene’s price is currently Overvalued.
            Does Adagene pay dividends?
            Adagene does not currently pay dividends.
            What is Adagene’s EPS estimate?
            Adagene’s EPS estimate is -$0.47.
              How many shares outstanding does Adagene have?
              Adagene has 43,790,000 shares outstanding.
                What happened to Adagene’s price movement after its last earnings report?
                Adagene reported an EPS of -$0.6 in its last earnings report, missing expectations of -$0.495. Following the earnings report the stock price went down -4.372%.
                  Which hedge fund is a major shareholder of Adagene?
                  Currently, no hedge funds are holding shares in ADAG


                  Adagene Stock Analysis

                  Smart Score
                  Price Target
                  No data currently available
                  The Adagene stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  Adagene Inc is a clinical-stage immunotherapy company focused on the design and discovery of antibodies for the treatment of cancer.

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis